More non-survivors presented with a history of chronic kidney disease; showed symptoms of dyspnea, lung moist rales, and higher BUN; had lower albumin and PaO2 levels; had complications of CMV infection; and received second-line therapy (all P < 0.05). This evidence concerns the gene ALB and cytomegalovirus infection.